Enquiry/Quote
Linaclotide bulk supplier for pharma manufacturers

Linaclotide Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 72 mcg, 145 mcg, 290 mcg

Reference Brands: Linzess (USA), Constella (EU)

Category: Gastrointestinal Drugs

Linaclotide is used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It works by increasing fluid secretion in the intestines, helping ease bowel movements and reduce abdominal discomfort. It is taken orally once daily.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

πŸ“˜ Sourcing Guide
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Linaclotide is used to treat chronic idiopathic constipation and irritable bowel syndrome with constipation by increasing intestinal fluid secretion.

Linaclotide is a synthetic 14-amino-acid peptide that acts as a guanylate cyclase-C agonist.

The trade name is Linzess.

Linzess is made by Ironwood Pharmaceuticals and AbbVie (Allergan).

The generic name is linaclotide.

The brand name is Linzess.

It is primarily manufactured in the United States for Ironwood Pharmaceuticals and AbbVie.

Related Products

Bismuth Subsalicylate

Strength:
262 mg, 525 mg

Form: Oral suspension / Tablet

Reference Brands: Pepto-Bismol (USA/LATAM),

View Details
Plecanatide

Strength:
3 mg

Form: Tablets

Reference Brands: Trulance (USA)

View Details
Naldemedine

Strength:
0.2 mg

Form: Tablets

Reference Brands: Symproic (USA/EU)

View Details
Resmetirom

Strength:
80 mg ,100 mg

Form: Tablets

Reference Brands: Rezdiffra (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.